H-gamma2 heavy chain Homo sapiens (1-447) [VH (Homo sapiens IGHV5-51*01 (98.0%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121) -Homo sapiens IGHG2*01 G2m.. CH2 V45.1, G2v3 CH2 A1.2, A1, S2, A30, L92, S115, S116 (CH1 P92>T (193) (122-219), hinge 1-12 (220-231), CH2 V1.2>A (235), G1>A (237), P2>S (238), H30>A (268), V45.1 (282), V92>L (309), A115>S (330), P116>S(331) (232-340), CH3 (341-445), CHS (446-447)) (341-447)], (135-220')-disulfide with L-kappa light chain Homo sapiens (1'-220') [V-KAPPA (Homo sapiens IGKV4-1*01 (92.1%) -IGKJ1*01 (100%), CDR-IMGT [12.3.9] (27'-38'.56'-58'.95'-103')) (1'-113') -Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPA A45.1 (159'), V101 (197')) (114'-220')]; dimer (223-223'':224-224'':227-227'':230-230'')-tetrakisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1SV, glycoform alfa
Pain
GlaxoSmithKlinemonoclonal_antibodyPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
43 Active assets in the Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Bursa City Hospital | Phase 4 | BBB |
Tapentadol Grünenthal GmbH | Phase 4 | BBB |
Oxycodone The First Affiliated Hospital with Nanjing Medical University | Phase 4 | BBB |
FENTANYL Aga Khan University | Phase 4 | BBB |
Nabiximols Jazz Pharmaceuticals | Phase 3 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →